Bullous pemphigoid (BP) has been repeatedly reported to occur following exposure to the severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study analyzes the molecular mimicrybetween the 180 kDa bullous pemphigoid antigen 2 (BP180) and the SARS-CoV-2 proteome to further ourunderstanding of the molecular link between the BP and the SARS-CoV-2 infection. Results indicate a highdegree of molecular mimicry between BP180, SARS-CoV-2, hCoV-229E and hCoV-NL63.
Peptide sharing between SARS-CoV-2 and Bullous pemphigoid 180
M. Petruzzi
2022-01-01
Abstract
Bullous pemphigoid (BP) has been repeatedly reported to occur following exposure to the severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study analyzes the molecular mimicrybetween the 180 kDa bullous pemphigoid antigen 2 (BP180) and the SARS-CoV-2 proteome to further ourunderstanding of the molecular link between the BP and the SARS-CoV-2 infection. Results indicate a highdegree of molecular mimicry between BP180, SARS-CoV-2, hCoV-229E and hCoV-NL63.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2022 JBRHA Peptide sharing between SARS-CoV-2 and Bullous pemphigoid 180.pdf
non disponibili
Descrizione: Article
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright dell'editore
Dimensione
372.68 kB
Formato
Adobe PDF
|
372.68 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
